Benefits of lower neonatal platelet transfusion thresholds

Key Ideas Degree of thrombocytopenia is not a predictor of bleeding risk in neonates, yet most platelet transfusions are given prophylactically in non‐bleeding premature infants. Recent data support a lower platelet transfusion threshold of 25 × 10 9 /L in non‐bleeding premature neonates and indicate that higher transfusion thresholds may be associated with harm including increased risk of death and bleeding. The mechanism of increased adverse events with higher platelet transfusion threshold is unknown, but considerations include adult platelets disrupting the neonatal hemostatic balance of hypoactive platelets in a hypercoagulable and fragile environment and having a pro‐inflammatory effect.